在2型糖尿病患者中,GALNT2表达与血糖控制和血清代谢物有关
Vincenzo Trischitta1,2, Alessandra Antonucci3,4, Jerzy Adamski5,6,7
1Research Unit of Diabetes and Endocrine Diseases, Fondazione IRCCS Casa Sollievo Della Sofferenza, 71013, San Giovanni Rotondo, Foggia, Italy. vincenzo.trischitta@uniroma1.it.
Acta diabetologica
|April 16, 2024
概括
在2型糖尿病中,GALNT2表达与HbA1c和特定代谢物如甘氨酸相关. 这表明GALNT2影响葡萄糖控制和胰岛素敏感性,因此需要进一步研究其代谢作用.
科学领域:
- 代谢研究的研究.
- 糖尿病是一种糖尿病.
- 分子生物学分子生物学
背景情况:
- 葡萄糖代谢和胰岛素敏感性在2型糖尿病中至关重要.
- 已知GALNT2酶可以积极调节胰岛素敏感性.
- 了解糖尿病代谢失调的分子基础是必不可少的.
研究的目的:
- 研究2型糖尿病患者GALNT2表达水平和代谢特征之间的关联.
- 探索GALNT2表达和关键临床参数之间的关系,包括HbA1c.
- 为了确定与GALNT2表达相关的特定血清代谢物.
主要方法:
- 针对性代谢学被用来分析来自70名2型糖尿病患者血清中的5个代谢物家族.
- 在外围白细胞中,用RT-PCR量化了GALNT2的表达.
- 统计分析包括错误发现率,逐步选择和多变量模型来评估关联,控制混因素.
主要成果:
- GALNT2表达与HbA1c水平独立相关 (P=0.0052).
- 在GALNT2表达和血清中的甘氨酸,乙胺和氨酸水平之间发现了显著的关联.
- 观察到的GALNT2表达与HbA1c之间的关联并非由甘氨酸,乙胺或氨酸介导.
结论:
- 在2型糖尿病患者中,GALNT2表达与特定的血清代谢物有关.
- 这些发现强调了GALNT2在调解胰岛素敏感性,血糖控制和其他糖尿病临床特征的影响方面的潜在作用.
- 需要进一步的研究来阐明这些关联背后的精确机制.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Glucose Transporters
22.7K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.7K
Oral Hypoglycemic Agents: Biguanides and Glitazones
195
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
195
Diabetes: Symptoms, Diagnosis, and Complications
528
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
528
Diabetes: Management and Pharmacotherapy
275
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
275


